Here, the hypothesis that E2-induced NGB accumulation is a conserved compensatory mechanism important for breast cancer progression, by averting mitochondrial apoptosis, has been evaluated in ERα-expressing breast ductal carcinoma tissue samples with different grades derived from patients who were not subjected to chemotherapy or endocrine treatments earlier. This evidence concerns the gene ESR1 and breast ductal adenocarcinoma.